AOD-9604 vs GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like Semaglutide and Tirzepatide represent the current standard for medication-assisted weight loss, producing dramatic results averaging 15-20% total body weight reduction
Research into 5-Amino-1MQ has been conducted primarily in preclinical (animal and cellular) models, and it has not been approved by the MHRA, NICE, or any major regulatory authority for human therapeutic use
Great service and product Good product
Very good gave me the right energy I needed Awesome product- A+++++++++ gives me a good energy boost in the afternoon My brain fog, which I had been suffering with since a surgery in 2018 is pretty much gone Easy refill and quick delivery
In a 23-week trial, subjects taking 1mg daily lost an average of 2.8kg compared to 0.8kg for placebo
Even if youre not in the danger zone, a clinical study published in the Cochrane Library has noted that B12 plays a significant role in preventing neurological decline and maintaining metabolic health